Trending Stocks: PTC Therapeutics, GrubHub, Best Buy Co, and More

PTC Therapeutics, Inc. (NASDAQ:PTCT) has surged more than 63% after the Committee for Medicinal Products for Human Use recommended the renewal of the conditional marketing authorization of Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients five years and older. Due to previous circumstances, some traders didn’t think that the CHMP would give the drug its recommendation. Given that the CHMP opinion forms the basis for a European Commission decision on the renewal of the marketing authorization, the probability that the European Commission will renew the marketing authorization is now greater. 13 top funds had a bullish position in PTC Therapeutics, Inc. (NASDAQ:PTCT) at the end of the second quarter, up one fund from the previous quarter.

Deutsche Bank AG (USA) (NYSE:DB) has inched up more than 1.4% after analysts at Barclays said that a Department of Justice settlement for Deutsche  bank could be less costly and faster when Trump becomes President. Settling the DOJ shady mortgage securities case without substantially draining its capital reserves would be a huge plus for the bank if the scenario occurred. According to our records, 15 savvy funds were long Deutsche Bank AG (USA) (NYSE:DB) at the end of the second quarter. That’s up five from the end of March.

Last but not least, traders are watching CONSOL Energy Inc. (NYSE:CNX) after John Gerdes of KLR Group upgraded the stock to ‘Buy’ from ‘Accumulate’. The analyst likes the stock’s valuation given the recent dip in shares. Gerdes has a $25 price target. Shares of Consol are nevertheless down due to broader sector weakness. 34 funds tracked by Insider Monkey were long $1.48 billion of CONSOL Energy Inc. (NYSE:CNX) and accounted for 40.00% of the float on June 30.

Disclosure:None